Bay Area Open Science Group: OpenADMET - Raising the bar on ADMET prediction with open science
Free
- Length
- 1 hr
- Platform
- Zoom
- Topic
- Medical & Clinical
About this webinar
This month, Dr. Pat Walters is joining us to talk about the OpenADMET initiative. Drug discovery programs frequently stall due to the Avoid-ome, which comprises the complex off-target interactions and ADMET liabilities that traditional heuristic methods struggle to address. To solve this, OpenADMET combines high-resolution structural biology, directed data generation, and machine learning into a systematic framework for predicting and mitigating these liabilities. Central to this mission is generating targeted datasets to host large-scale blind benchmarks that test community predictive models on real-world drug design problems. By uniting hundreds of academic and industry teams through these challenges, webinars, and conferences, the initiative fosters widespread collaboration to establish transparent, data-driven standards across the field.